explore -WSS

explore

author：explore 2025-09-28 21:57:11 - browse：5

Adobe

LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to diversify its pipeline.

Under the deal, Merck, through a subsidiary, will pay $1.3 billion in cash upfront, with another $1.7 billion potentially included if certain regulatory and commercial milestones are met. The Wall Street Journal first reported the news Tuesday night.

EyeBio has been developing a drug called restoret for a number of retinal diseases, including age-related macular degeneration and diabetic macular edema. It presented data in February from a Phase 1/2 trial of restoret in both conditions. Merck said it plans to move restoret into a pivotal trial for diabetic macular edema later this year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Attacks on the drug industry will lead to fewer breakthroughs

WSS

Couple fighting to bring baby home from Mexico are finally reunited

The kidney, in all its complexity, is captured in a new atlas

Verily hires former Apple Health leader as chief scientific officer

Seattle police shoot person suspected in downtown stabbing

Couple fighting to bring baby home from Mexico are finally reunited

States increasingly look to regulate hospital facility fees

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Peter Hotez and the public health issue of online harassment

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Supreme Court strikes down use of affirmative action

Dramatically reducing cancer deaths requires the PASTEUR Act

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

At least 13 dead in Texas as scorching temps continue

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

knowledge

Stem cell clinics for heart failure: buyer be wary

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Man who had jail sentence commuted by Trump arrested again

Stanford updates investigation of president’s past research

'Reaching a detente': STAT's Helen Branswell on covering Covid

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

leisure time

knowledge

entertainment

entertainment